Federal Employees Not Eligible for Social Security Benefits: United States Court of Appeals

Published Date: 16 Feb 2023

A divided U.S. appeals court ruled on Tuesday that federal workers generally do not deserve extra pay for being exposed to the COVID-19 virus on the job.

Read Full News

Latest News

Dolutegravir Shows Continued Success in Youth With HIV

Dolutegravir reduces viral load in adolescents and children in low- to middle-income nations.

US CDC Deploys Staff to Curb South Carolina's Measles Outbreak

(Refiles to remove extraneous word years from first paragraph)

After FDA Declined Review, EMA Backs 1st Flu-COVID mRNA Vax

The Moderna vaccine will likely be available in Europe long before the US.

Peak Anti-HBs Level May Predict Protection in HIV Infection

Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.

Doravirine Plus Islatravir Matches Standard HIV Therapy

In patients with HIV‑1 infection and virologic suppression, switching to an investigational regimen of doravirine plus islatravir shows efficacy and safety similar to standard ART regimens.

European Guidance Advances Cardiovascular Risk Assessment

The 2025 update integrates new risk estimation tools and shifts acute coronary syndrome management toward earlier intensive lipid-lowering therapy.

Todays Updates

Have the Harms of Lung Cancer Screening Been Exaggerated?

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Despite FDA package insert recommendations, most patients with breast cancer who are prescribed CDK4/6 inhibitors do not receive liver function tests before starting treatment.

Alternative Medicine for Breast Cancer: Study Raises Concern

Patients who receive both standard medical treatment and complementary and alternative therapies have higher mortality — possibly due to reduced use of endocrine therapy and radiation.

Todays Updates

Have the Harms of Lung Cancer Screening Been Exaggerated?

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy

Despite FDA package insert recommendations, most patients with breast cancer who are prescribed CDK4/6 inhibitors do not receive liver function tests before starting treatment.

Alternative Medicine for Breast Cancer: Study Raises Concern

Patients who receive both standard medical treatment and complementary and alternative therapies have higher mortality — possibly due to reduced use of endocrine therapy and radiation.

Latest News

Dolutegravir reduces viral load in adolescents and children in low- to middle-income nations.

(Refiles to remove extraneous word years from first paragraph)

The Moderna vaccine will likely be available in Europe long before the US.

Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.

In patients with HIV‑1 infection and virologic suppression, switching to an investigational regimen of doravirine plus islatravir shows efficacy and safety similar to standard ART regimens.

The 2025 update integrates new risk estimation tools and shifts acute coronary syndrome management toward earlier intensive lipid-lowering therapy.

News All Time

CROI 2026

Read clinically focused news coverage of key developments from CROI 2026.

Response to RSV Varies With Age

Tissue modeling outlines how respiratory syncytial virus promotes different disease outcomes in children and adults.

US CDC Vaccine Panel to Meet in March After February Session Scrapped

The U.S. Centers for Disease Control and Prevention's vaccine advisory committee is set to meet on March ⁠18 to 19, an update on the agency's website showed on Tuesday,...

Zimbabwe Ends $367 Million Health Funding Talks With US

Zimbabwe has pulled out of talks on a $367 million bilateral health agreement with the US due to concerns over sharing sensitive health data in return for financial support.

Long-Acting HIV Drug Switch Shows No Major Metabolic Impact

In patients with HIV infection, a switch to long acting cabotegravir plus rilpivirine shows no clinically meaningful changes in body composition or adverse metabolic effects over 48 weeks.

Mobile Telemedicine Boosts Rural Access to HCV Treatment

Among rural people with chronic HCV infection and a history of injection drug use, a mobile telemedicine-based intervention vs enhanced usual care improves treatment initiation and cure rates.

RSV Vaccine in Multidose Vial Matches Single-Dose Vial

In healthy, nonpregnant women, the multidose vial of RSVpreF vaccine produces immune responses and safety outcomes comparable to the single-dose vial, a trial finds.

US FDA Reverses Course, Will Review Moderna's Flu Vaccine Application

Moderna said on Wednesday the U.S. Food and Drug Administration changed course and will review an amended application for its new flu vaccine, a week after rejecting the...

AAP Finds No New Evidence Against Hep B Vaccine Birth Dose

AAP publishes review of safety and efficacy of hepatitis B vaccination birth dose.

Healthy Life Expectancy Declines Again

Years spent in good health have dropped to their lowest level since comparable data were first collected in 2011 to 2013, with stark regional gaps across the UK.

Long-Acting HIV Therapy May Be Safe After HBV Exposure

Switching to a long-acting cabotegravir/rilpivirine antiretroviral regimen may be safe for patients with HIV who have prior hepatitis B virus exposure, a real-world study shows.

Next-Day HIV Test Result Show Mixed Effects on Seeking Care

Next-day HIV viral load test results do not improve overall linkage to care when added to standard testing but are tied to faster linkage to antiretroviral therapy among people with HIV infection.

ED Screening Uncovers Elevated Risk for Cervical Cancer

Emergency department-based cervical cancer interventions identify precancerous lesions and high-risk human papillomavirus at rates higher than the national average, a study shows.

Cancer Screening Gaps Leave People With HIV at Elevated Risk

International guidelines recommend anal and liver surveillance for people with HIV, but Brazil lacks a national protocol; clinicians should integrate screening and vaccination.

Pritelivir Shows Promise for HSV

The new oral therapy demonstrates superior lesion healing for complex patients who have few current treatment options.

STI Prevention With Doxycycline Raises Resistance Fears

Public health authorities warn clinicians to weigh risks and enroll patients in supervised programs: routine testing, partner management, and resistance surveillance are essential.

Recommended News For You

High resolution ultrasound could enable faster prostate cancer diagnosis

Early Esophageal Cancer pCR Rates Are Raised by Neoadjuvant PD-1 Blockade.

Novel radiotracer identifies biomarker for triple-negative breast cancer

Physician Fights Insurer to Cover Her Baby's Brain Cancer Treatment

Cancer cells with thick glycocalyx barrier evade immune system better: study

Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice

Research finds stark disparities in treatment and survival time for people with pancreatic cancer

Recommended Articles For You

Unlocking the Mystery of Leukemia: Exploring New Treatments and Hope for Patients 

Management of Relapsed Synovial Sarcoma: Current Treatment Strategies and Emerging Therapies 

The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide 

CEUS in Endometrial Cancer: A Tool for Early Myometrial Infiltration Detection 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Radioiodine therapy found to improve relative survival rates of differentiated thyroid cancer patients

2.

Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.

3.

World's premier cancer institute faces crippling cuts and chaos

4.

For treatment, the majority of cancer patients choose complementary therapies.

5.

Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC

1.

Exploring the Causes and Treatments of Thrombocytopenia: A Comprehensive Guide

2.

Cancer Vaccines In India: The Latest Hope In The Fight Against Disease

3.

Transforming Cancer Care: Metrics, Informatics, Equity, and Real-World Evidence

4.

Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer

5.

Unveiling the Mystery Behind Castleman Disease – Understanding Its Causes and Symptoms 

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part III

2.

Efficient Management of First line ALK-rearranged NSCLC - Part II

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

4.

CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion

5.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot